Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase III Study of 5-Fluorouracil-based Regimen With or Without Oxaliplatin as 2nd Line Treatment of Advanced or Metastatic Pancreatic Cancer in Patients Who Have Previously Received Gemcitabine-based Chemotherapy

NCT01121848 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT01121848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01121848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase III Study of 5-Fluorouracil-based Regimen With or Without Oxaliplatin as 2nd Line Treatment of Advanced or Metastatic Pancreatic Cancer in Patients Who Have Previously Received Gemcitabine-based Chemotherapy
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2010
Completion date
October 31, 2013
Enrollment
108 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic neoplasms